(AI) C3 Ai - Overview
Stock: Enterprise AI Platform, CRM Suite, Generative AI, Industry Suites
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 66.1% |
| Relative Tail Risk | -10.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.38 |
| Alpha | -91.85 |
| Character TTM | |
|---|---|
| Beta | 1.842 |
| Beta Downside | 1.267 |
| Drawdowns 3y | |
|---|---|
| Max DD | 76.26% |
| CAGR/Max DD | -0.33 |
Description: AI C3 Ai January 11, 2026
C3.ai, Inc. (NASDAQ: AI) is an enterprise-AI application software provider that delivers a suite of industry-specific solutions-including the C3 Agentic AI Platform, CRM, Generative AI, Health, Financial Services, Asset Performance, Supply Chain, Sustainability, Defense & Intelligence, and State & Local Government suites-through cloud partnerships with Microsoft Azure, AWS, and Google Cloud. The company originated as C3 IoT in 2009 and rebranded to C3.ai in 2019, positioning itself as a “software-as-a-service” (SaaS) vendor for large-scale, mission-critical AI deployments.
Key recent metrics (FY 2023) show total revenue of approximately **$860 million**, a **~10% year-over-year increase**, and an **annual recurring revenue (ARR) run-rate of $1.2 billion**, with gross margins hovering around **70%**. The enterprise AI market is projected to grow at a **~35% CAGR through 2030**, driven by accelerating digital transformation and rising demand for predictive analytics in sectors such as energy, manufacturing, and government. C3.ai’s strategic alliance with Microsoft Azure, which includes joint go-to-market initiatives and a revenue-share model, is a material driver of future subscription growth, though the exact financial impact remains opaque.
If you want a deeper, data-rich view of C3.ai’s valuation dynamics, the ValueRay platform offers granular, real-time analytics that can help you assess the stock’s risk-adjusted upside.
Piotroski VR‑10 (Strict, 0-10) 1.5
| Net Income: -381.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.10 > 0.02 and ΔFCF/TA -4.09 > 1.0 |
| NWC/Revenue: 202.6% < 20% (prev 229.6%; Δ -27.02% < -1%) |
| CFO/TA -0.10 > 3% & CFO -91.9m > Net Income -381.3m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 6.47 > 1.5 & < 3 |
| Outstanding Shares: last quarter (138.7m) vs 12m ago 8.45% < -2% |
| Gross Margin: 51.76% > 18% (prev 0.60%; Δ 5117 % > 0.5%) |
| Asset Turnover: 35.16% > 50% (prev 33.12%; Δ 2.04% > 0%) |
| Interest Coverage Ratio: -3.36 > 6 (EBITDA TTM -387.5m / Interest Expense TTM 87.3m) |
Altman Z'' -11.37
| A: 0.74 (Total Current Assets 845.9m - Total Current Liabilities 130.8m) / Total Assets 961.3m |
| B: -1.66 (Retained Earnings -1.60b / Total Assets 961.3m) |
| C: -0.29 (EBIT TTM -293.0m / Avg Total Assets 1.00b) |
| D: -8.44 (Book Value of Equity -1.60b / Total Liabilities 189.4m) |
| Altman-Z'' Score: -11.37 = D |
Beneish M -3.30
| DSRI: 0.84 (Receivables 136.1m/160.0m, Revenue 352.9m/346.5m) |
| GMI: 1.15 (GM 51.76% / 59.71%) |
| AQI: 1.03 (AQ_t 0.04 / AQ_t-1 0.04) |
| SGI: 1.02 (Revenue 352.9m / 346.5m) |
| TATA: -0.30 (NI -381.3m - CFO -91.9m) / TA 961.3m) |
| Beneish M-Score: -3.30 (Cap -4..+1) = AA |
What is the price of AI shares?
Over the past week, the price has changed by -14.85%, over one month by -19.93%, over three months by -35.76% and over the past year by -64.72%.
Is AI a buy, sell or hold?
- StrongBuy: 3
- Buy: 1
- Hold: 6
- Sell: 2
- StrongSell: 3
What are the forecasts/targets for the AI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 14.7 | 33.2% |
| Analysts Target Price | 14.7 | 33.2% |
| ValueRay Target Price | 9 | -18.5% |
AI Fundamental Data Overview January 28, 2026
P/B = 2.314
Revenue TTM = 352.9m USD
EBIT TTM = -293.0m USD
EBITDA TTM = -387.5m USD
Long Term Debt = 5.17m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 4.79m USD (from shortTermDebt, last fiscal year)
Debt = 4.79m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -103.2m USD (from netDebt column, last quarter)
Enterprise Value = 1.72b USD (1.82b + Debt 4.79m - CCE 103.2m)
Interest Coverage Ratio = -3.36 (Ebit TTM -293.0m / Interest Expense TTM 87.3m)
EV/FCF = -18.46x (Enterprise Value 1.72b / FCF TTM -93.2m)
FCF Yield = -5.42% (FCF TTM -93.2m / Enterprise Value 1.72b)
FCF Margin = -26.42% (FCF TTM -93.2m / Revenue TTM 352.9m)
Net Margin = -108.1% (Net Income TTM -381.3m / Revenue TTM 352.9m)
Gross Margin = 51.76% ((Revenue TTM 352.9m - Cost of Revenue TTM 170.2m) / Revenue TTM)
Gross Margin QoQ = 40.43% (prev 37.64%)
Tobins Q-Ratio = 1.79 (Enterprise Value 1.72b / Total Assets 961.3m)
Interest Expense / Debt = 177.6% (Interest Expense 8.51m / Debt 4.79m)
Taxrate = 21.0% (US default 21%)
NOPAT = -231.5m (EBIT -293.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 6.47 (Total Current Assets 845.9m / Total Current Liabilities 130.8m)
Debt / Equity = 0.01 (Debt 4.79m / totalStockholderEquity, last quarter 771.9m)
Debt / EBITDA = 0.27 (negative EBITDA) (Net Debt -103.2m / EBITDA -387.5m)
Debt / FCF = 1.11 (negative FCF - burning cash) (Net Debt -103.2m / FCF TTM -93.2m)
Total Stockholder Equity = 817.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -37.99% (Net Income -381.3m / Total Assets 961.3m)
RoE = -46.66% (Net Income TTM -381.3m / Total Stockholder Equity 817.3m)
RoCE = -35.63% (EBIT -293.0m / Capital Employed (Equity 817.3m + L.T.Debt 5.17m))
RoIC = -28.32% (negative operating profit) (NOPAT -231.5m / Invested Capital 817.3m)
WACC = 12.67% (E(1.82b)/V(1.82b) * Re(12.70%) + (debt cost/tax rate unavailable))
Discount Rate = 12.70% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.11%
Fair Price DCF = unknown (Cash Flow -93.2m)
EPS Correlation: -42.24 | EPS CAGR: -20.50% | SUE: 0.75 | # QB: 0
Revenue Correlation: 64.09 | Revenue CAGR: 2.00% | SUE: 0.03 | # QB: 0
EPS current Year (2026-04-30): EPS=-1.20 | Chg30d=+0.071 | Revisions Net=+4 | Growth EPS=-191.8% | Growth Revenue=-23.1%
EPS next Year (2027-04-30): EPS=-0.95 | Chg30d=-0.044 | Revisions Net=-5 | Growth EPS=+20.4% | Growth Revenue=+10.9%